Jinling Pharmaceutical Co Ltd
000919
Company Profile
Business description
Jinling Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company is engaged in production and sales of Chinese and Western medicine raw materials and preparations, biochemical products, pharmaceutical packaging products, medical devices, and natural beverages.
Contact
No. 238 Zhongyang Road
Jinling Pharmaceutical Building
NanjingJiangsu210009
CHNT: +86 2583118511
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
5,789
Stocks News & Analysis
stocks
The ‘other’ AI chip behemoth that might just be getting started
The magnitude of growth at Broadcom continues to astound us.
stocks
Why ANZ changes aren’t just about cutting costs
The banking major needs to prevent key product offerings from falling further behind the competition.
stocks
Strong finish to the year for overvalued ASX share
A great fiscal 2025 but investors are ahead of themselves.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,095.20 | 28.80 | 0.32% |
| CAC 40 | 7,753.30 | 3.91 | 0.05% |
| DAX 40 | 23,600.47 | 117.98 | -0.50% |
| Dow JONES (US) | 45,655.16 | 56.18 | -0.12% |
| FTSE 100 | 9,240.08 | 2.45 | -0.03% |
| HKSE | 26,200.26 | 262.13 | 1.01% |
| NASDAQ | 21,986.28 | 106.79 | 0.49% |
| Nikkei 225 | 43,837.67 | 378.38 | 0.87% |
| NZX 50 Index | 13,276.24 | 22.51 | 0.17% |
| S&P 500 | 6,553.46 | 40.85 | 0.63% |
| S&P/ASX 200 | 8,830.40 | 40.00 | 0.46% |
| SSE Composite Index | 3,812.22 | 4.93 | 0.13% |